Gapping down
In reaction to disappointing earnings/guidance:
In reaction to disappointing earnings/guidance:
- N/A.
Other news:
- PZRX -59% (elects to file a voluntary petition under Chapter 11)
- SYRS -49.5% (reports initial clinical data from ongoing Phase 2 Trial of SY-1425)
- ONCE -25.1% (Hemophilia B update at ASH)
- GBT -7% (reports new Phase 2a data for Voxelotor in adolescents with Sickle Cell Disease)
- CYTK -2.5% (presentation of results from VITALITY-ALS -- did not meet primary or secondary endpoints)
- SNOA -2.3% (entered into $5 mln At Market Issuance Sales Agreement, or the Sales Agreement, with B. Riley FBR)
- LPTX -2% (files for 3,734,914 share common stock offering by holders)
Analyst comments:
- PCAR -1.1% (downgraded to Neutral from Overweight at JP Morgan)